Modulating Wnt signaling to improve cell replacement therapy for Parkinson's disease

CL Parish, LH Thompson - Journal of molecular cell biology, 2014 - academic.oup.com
Clinical trials have demonstrated the capacity for dopamine neurons, transplanted
ectopically into the striatum, to structurally integrate, restore dopamine transmission, and …

A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat …

E Lonardo, CL Parish, S Ponticelli, D Marasco… - Stem …, 2010 - academic.oup.com
Cripto is a glycosylphosphatidylinositol-anchored coreceptor that binds Nodal and the
activin type I (ALK)-4 receptor, and is involved in cardiac differentiation of mouse embryonic …

Ryk receptors on unmyelinated nerve fibers mediate excitatory synaptic transmission and CCL2 release during neuropathic pain induced by peripheral nerve injury

QO Yang, WJ Yang, J Li, FT Liu, H Yuan… - Molecular …, 2017 - journals.sagepub.com
Background Neuropathic pain is a major pathology of the central nervous system associated
with neuroinflammation. Ryk (receptor-like tyrosine kinase) receptors act as repulsive axon …

Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease

L Zhang, H Yang - Molecular Biology Reports, 2024 - Springer
Parkinson's disease (PD) is a neurodegenerative disease, the most characteristic
pathological feature is the progressive loss of dopaminergic (DA) neurons in the substantia …

[HTML][HTML] NMDA receptor activation stimulates transcription-independent rapid wnt5a protein synthesis via the MAPK signaling pathway

Y Li, B Li, X Wan, W Zhang, L Zhong, SJ Tang - Molecular brain, 2012 - Springer
Wnt proteins are emerging key regulators of the plasticity and functions of adult brains.
However, the mechanisms by which the expression of Wnt proteins is regulated in neurons …

[HTML][HTML] ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease

M Verma, EK Steer, CT Chu - … et Biophysica Acta (BBA)-Molecular Basis of …, 2014 - Elsevier
The leucine rich repeat kinase 2 (LRRK2/dardarin) is implicated in autosomal dominant
familial and sporadic Parkinson's disease (PD); mutations in LRRK2 account for up to 40 …

[HTML][HTML] LRRK2: an éminence grise of Wnt-mediated neurogenesis?

DC Berwick, K Harvey - Frontiers in cellular neuroscience, 2013 - frontiersin.org
The importance of leucine-rich repeat kinase 2 (LRRK2) to mature neurons is well-
established, since mutations in PARK8, the gene encoding LRRK2, are the most common …

Oxidative Stress Induces an Interactive Decline in Wnt and Nrf2 Signaling in Degenerating Retinal Pigment Epithelium

KB Ebrahimi, M Cano, J Rhee, S Datta… - Antioxidants & Redox …, 2018 - liebertpub.com
Aims: Cells have evolved a highly sophisticated web of cytoprotective systems to neutralize
unwanted oxidative stress, but are challenged by unique modern day stresses such as …

Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells

CM Schwartz, T Tavakoli, C Jamias… - Journal of …, 2012 - Wiley Online Library
Human embryonic stem cell (hESC)‐derived dopaminergic (DA) neurons hold potential for
treating Parkinson's disease (PD) through cell replacement therapy. Generation of DA …

Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens

D Ribeiro, RL Goya, G Ravindran, R Vuono… - Neurobiology of …, 2013 - Elsevier
Human fetal midbrain tissue grafting has provided proof-of-concept for dopamine cell
replacement therapy (CRT) in Parkinson's disease (PD). However, limited tissue availability …